Afya (NASDAQ:AFYA – Get Free Report) had its price target reduced by analysts at JPMorgan Chase & Co. from $25.00 to $20.50 in a research report issued to clients and investors on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 30.41% from the stock’s previous close.
Separately, The Goldman Sachs Group started coverage on shares of Afya in a report on Tuesday, December 3rd. They issued a “sell” rating and a $16.00 target price for the company. One analyst has rated the stock with a sell rating and four have issued a hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $19.60.
Afya Trading Up 0.4 %
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the business. Marshall Wace LLP grew its stake in shares of Afya by 41.8% during the second quarter. Marshall Wace LLP now owns 336,985 shares of the company’s stock worth $5,948,000 after acquiring an additional 99,416 shares during the last quarter. Millennium Management LLC grew its position in Afya by 45.0% during the 2nd quarter. Millennium Management LLC now owns 291,164 shares of the company’s stock worth $5,139,000 after purchasing an additional 90,383 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in Afya during the 3rd quarter valued at approximately $842,000. Erste Asset Management GmbH purchased a new position in shares of Afya in the third quarter worth $822,000. Finally, Renaissance Technologies LLC lifted its stake in shares of Afya by 19.7% during the second quarter. Renaissance Technologies LLC now owns 266,500 shares of the company’s stock worth $4,704,000 after buying an additional 43,800 shares during the period. 88.02% of the stock is owned by institutional investors and hedge funds.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Stories
- Five stocks we like better than Afya
- What is a support level?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What Are Trending Stocks? Trending Stocks Explained
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
- What is the Dow Jones Industrial Average (DJIA)?
- Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.